ARK Genomic Revolution ETF (ARKG)

Profile

ARK Genomic Revolution ETF is an actively managed exchange-traded fund focused on companies participating in the genomics revolution. ARK Genomic Revolution ETF invests primarily in equity securities across sectors such as health care, information technology, materials, energy, and consumer discretionary, targeting businesses involved in areas like gene editing, bioinformatics, molecular diagnostics, targeted therapeutics, and multiomics innovation. The fund is designed to provide diversified exposure to a fast-evolving part of the healthcare and life sciences ecosystem, where advances in data, diagnostics, and genetic technologies are reshaping how disease is detected and treated. By concentrating on companies tied to genomic innovation, ARK Genomic Revolution ETF serves as a thematic vehicle for investors seeking exposure to the intersection of biotechnology, healthcare, and technology markets.